JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

This protocol establishes a novel method of lipid droplet isolation and purification from mouse livers, using a well-established endoplasmic reticulum isolation kit.

Streszczenie

Lipid droplets (LDs) are bioactive organelles found within the cytosol of the most eukaryotic and some prokaryotic cells. LDs are composed of neutral lipids encased by a monolayer of phospholipids and proteins. Hepatic LD lipids, such as ceramides, and proteins are implicated in several diseases that cause hepatic steatosis. Although previous methods have been established for LD isolation, they require a time-consuming preparation of reagents and are not designed for the isolation of multiple subcellular compartments. We sought to establish a new protocol to enable the isolation of LDs, endoplasmic reticulum (ER), and lysosomes from a single mouse liver.

Further, all reagents used in the protocol presented here are commercially available and require minimal reagent preparation without sacrificing LD purity. Here we present data comparing this new protocol to a standard sucrose gradient protocol, demonstrating comparable purity, morphology, and yield. Additionally, we can isolate ER and lysosomes using the same sample, providing detailed insight into the formation and intracellular flux of lipids and their associated proteins.

Wprowadzenie

LDs are bioactive organelles found in the cytosol of most eukaryotic cells and some prokaryotic cells1,2,3. The LD core is composed of neutral lipids such as triglyceride (TG) and cholesterol esters. They also contain ceramides, bioactive lipids involved in cellular signaling pathways4,5. LDs are surrounded by a phospholipid monolayer and coated with proteins, including the perilipin proteins perilipin 2 (PLIN2) and 3 (PLIN3)1,5,6. Also present are lipogenic enzymes, lipases, and membrane trafficking proteins that have been linked to several hepatic steatotic diseases, including nonalcoholic fatty liver disease, alcoholic liver disease, and hepatitis C3,5,6,7,8,9,10.

LDs are thought to form from the outer membrane of the ER and contain newly synthesized TG sourced from ER-derived free fatty acids11. However, it remains unknown whether the pooled lipids bud, remain connected, or are excised from the ER6,11, making the isolation of LDs free from ER technically challenging. Free fatty acids can be liberated from LDs by the action of surface lipases to provide for energy production or membrane synthesis. Additionally, LDs can be degraded via lipophagy as a regulatory mechanism and to produce free fatty acids12.

Besides the ER and lysosomes, there are other organelles—such as mitochondria, endosomes, peroxisomes, and the plasma membrane—that are found within close association of LDs11. This tight polygamy makes it difficult to perform a pure LD extraction. However, neutral lipids’ innate low density can be taken advantage of via centrifugation5.

Traditionally, LDs have been isolated using a sucrose density gradient1,5,13. However, these methods have not been designed to isolate other organelles. Additionally, they require the time-consuming preparation of reagents. This protocol adapts a commercially available ER isolation kit (see the Table of Materials) to allow for LD isolation. We use the extraction buffer provided by the kit, adding an LD isolation step. Furthermore, the protocol can also be used for ER and lysosomal isolation using the same samples, allowing for a more comprehensive image of the life cycle of LDs. To validate this new method, we assay LD yield, morphology, size, and purity. We compare the results presented here to those obtained with a widely used protocol utilizing a sucrose gradient for LD isolation.

We used a 10- to 12-week-old, 20 g female C57BL/6 mouse fasted for 16 h (food removal at 5.00 P.M. for a 9.00 A.M. LD isolation time) with free access to water. The typical yield for TG is 0.6 mg/g liver, and for LD protein, it is 0.25 mg/g liver. This provides enough material for ~10 immunoblots by SDS PAGE. The protocol below details the reagents used and a protocol suitable for a single 1 g liver. The sucrose gradient isolation protocol is adapted from Sato14 and Wu15.

Protokół

All experiments were conducted on a laboratory bench with personal protective equipment appropriate for biosafety level 1, including a lab coat, gloves, and safety goggles. Experiments were performed according to the protocols approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Pennsylvania. All efforts were made to minimize animal discomfort, and the animals were treated with humane care.

1. LD isolation using an ER isolation kit

  1. Preparation
    NOTE: The listed amounts are suitable for a single 1 g mouse liver.
    1. Prepare 10 mL of 1x isotonic extraction buffer (IE buffer, from the ER isolation kit) by diluting 2 mL of 5x IE buffer with 8 mL of ultrapure water. Cool the buffer by placing it on ice.
    2. Prepare 100 mL of 1x phosphate-buffered saline (PBS) by diluting 10 mL of 10x PBS in 90 mL of ultrapure water. Cool it by placing it on ice.
    3. Prepare 10 mL of 5% polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether (PGPE) by diluting 500 µL of PGPE in 9.5 mL of ultrapure water. Use a 1 mL syringe to measure out PGPE as it is viscous. Cool it by placing it on ice.
    4. Cool all tubes by placing them on ice: 1.7 mL microcentrifuge tubes, 15 mL centrifuge tubes, 50 mL high-speed centrifuge tubes, and 13 mL ultracentrifuge tubes.
    5. Cool all required centrifuges to 4 °C: a microcentrifuge, a high-capacity centrifuge for 15 mL tubes, a high-speed centrifuge for 50 mL tubes, and an ultracentrifuge.
    6. Sterilize forceps and dissection scissors by autoclaving.
  2. Tissue preparation
    1. Euthanize the mouse by placing it in a chamber filled with 100% CO­2 for 10 min. Confirm euthanasia by performing cervical dislocation.
    2. Using sterile forceps and dissection scissors, cut the skin and muscle layers of the abdomen on the posterior/anterior axis to expose the liver.
    3. Cut the ligaments connecting the liver to the diaphragm and intestine. Use forceps to pull the intestine away from the liver, toward the posterior, to expose the ligaments.
    4. Cut between the liver and the dorsal ribcage, moving from anterior to posterior until the liver is liberated.
    5. Transfer the liver to a cold 5 cm Petri dish with 10 mL of cold 1x PBS.
    6. Wash the liver 2x on a rocking platform in 10 mL of cold 1x PBS for 5 min at 4 °C in the 5 cm Petri dish. Pour off 1x PBS after the final wash.
    7. Use a size-10 sterile surgical blade (see the Table of Materials) to dice the liver into 3–5 mm pieces in the 5 cm Petri dish (Figure 1A).
    8. Wash the diced liver 2x with 10 mL of cold 1x PBS for 5 min at 4 °C in the 5 cm Petri dish.
      NOTE: For lysosome isolation, transfer 0.5 g of liver to a clean 45 mL homogenizer and follow the directions supplied by the lysosome extraction kit (see the Table of Materials).
    9. Decant 1x PBS and transfer the diced liver pieces to the cold 45 mL Dounce homogenizer. Ensure all pieces go to the bottom of the homogenizer.
    10. Add 7 mL of cold 1x IE buffer (from the ER isolation kit) and homogenize on ice by moving the pestle up and down 20x. Ensure that the pestle goes to the bottom of the homogenizer during each stroke.
    11. Transfer the homogenate (Figure 1B) to a cold 15 mL centrifuge tube.
    12. Rinse the homogenizer with 1 mL of cold 1x IE buffer (from the ER isolation kit) and add this to the rest of the homogenate.
  3. LD isolation
    1. Remove nuclei by centrifuging the homogenate in a high-capacity centrifuge at 1,000 x g for 10 min at 4 °C (Figure 1C).
    2. Transfer the postnuclear supernatant (PNS) to a new, cold 50 mL centrifuge tube. To prevent LD loss, ensure that any lipid gathered at the top of the 15 mL tube is resuspended before transferring the PNS.
    3. Take a 100 µL aliquot of the PNS for purity analysis and place it in a cold 1.7 mL microcentrifuge tube. Set it aside on ice.
    4. To remove mitochondria, centrifuge the PNS sample, not the aliquot, in a refrigerated high-speed centrifuge at 12,000 x g for 15 min at 4 °C.
      1. Optional: For crude LD (CLD) isolates (with cytosol and cell membrane contamination), collect the top lipid layer using a glass pipette and transfer it to a 1.7 mL microcentrifuge tube. Continue to section 1.4.
    5. Transfer the postmitochondrial supernatant (PMS) to an ultracentrifuge tube. To prevent LD loss, ensure that any lipid gathered at the top is resuspended before transferring the PMS.
    6. Take a 100 µL aliquot of the PMS for purity analysis and place it in a cold 1.7 mL microcentrifuge tube. Set it aside on ice.
    7. Fill an ultracentrifuge tube to the brim with cold 1x IE buffer to prevent the tube collapsing during ultracentrifugation.
    8. Balance the samples and centrifuge them in an ultracentrifuge at 100,000 x g for 60 min at 4 °C (Figure 1D).
    9. To remove the LD layer, tilt the tube at a 45° angle and use a glass pipette to aspirate. Transfer the pellet to a cold 1.7 mL microcentrifuge tube.
      NOTE: The pellet contains isolated ER. Use this fraction downstream for ER isolation.
    10. Collect 100 µL of the post-ER supernatant (PER) under the lipid layer for purity analysis.
  4. LD washing
    1. Add 1x PBS to the LD fraction collected in a 1.7 microcentrifuge tube, to a total volume of 1.3 mL.
    2. Vortex the sample.
    3. Centrifuge in a microcentrifuge at top speed for 5 min at 4 °C to pellet any cell debris. Warm the tube gently with hands to help resuspend the LD layer. Transfer the supernatant, including the lipid layer, to a new 1.7 mL microcentrifuge tube.
    4. Repeat steps 1.4.1–1.4.3 2x–3x, until the pellet is no longer visible.
    5. Add 1x PBS to the pellet-free LD supernatant to a final volume of 1.5 mL. Wash the lipid fraction by centrifugation in a microcentrifuge at top speed for 5 min at 4 °C.
    6. Remove 1 mL of 1x PBS (underneath the lipid layer) with a glass pipette without disturbing the lipid layer.
    7. Repeat steps 1.4.5 and 1.4.6 4x–5x, until the 1x PBS is visually transparent with no turbidity.
    8. Remove all 1x PBS below the lipid layer, using a glass pipette (Figure 1E).
    9. Use the result, a pure LD fraction, for downstream analysis.
  5. LD protein quantitation by bicinchoninic acid assay
    NOTE: Do not use a bicinchoninic acid assay (BCA) if LD morphology is to be assessed.
    1. Resuspend the LD in 500 μL of 5% PGPE.
    2. Boil the samples for 5 min at 95 °C, vortex them, and incubate the samples at room temperature for 5 min to cool.
    3. Repeat step 1.5.2 an additional 2x.
    4. Sonicate the samples for 5 min with a 30 s on/off cycle, at medium intensity.
    5. Normalize the samples by measuring the protein concentration in all purity analysis samples and in the LD fraction by BCA assay.

2. LD isolation using sucrose density gradient

  1. Preparation
    1. Make 200 mL of TE buffer (10 mM Tris-HCl [pH 7.4], 1 mM EDTA [pH 8.0]). Cool it by placing it on ice.
    2. Make 100 mL of 60% (w/v) sucrose solution in TE buffer by dissolving 60 g of sucrose in TE buffer, bringing the final volume to 100 mL. Cool it by placing it on ice.
    3. Make 6 mL of 40% (w/v) sucrose solution by adding 4 mL of 60% sucrose to 2 mL of TE buffer. Cool it by placing it on ice.
    4. Make 6 mL of 25% (w/v) sucrose solution by adding 2.5 mL of 60% sucrose to 3.5 mL of TE buffer. Cool it by placing it on ice.
    5. Make 4 mL of 10% (w/v) sucrose solution by adding 0.7 mL of 60% sucrose to 3.3 mL of TE buffer. Cool it by placing it on ice.
    6. Make 10 mL of protease and phosphatase inhibitor solution by adding one tablet of both protease and phosphatase inhibitors to 10 mL of TE buffer.
    7. Prepare tissue homogenate buffer by adding 4 mL of protease and phosphatase inhibitor solution to 50 mL of 60% sucrose stock solution. Cool it by placing it on ice.
    8. Prepare overlay buffer by adding 2 mL of protease and phosphatase inhibitor solution to 50 mL of TE buffer. Cool it by placing it on ice.
    9. Prepare 100 mL of 1x PBS by diluting 10 mL of 10x PBS in 90 mL of ultrapure water. Cool it by placing it on ice.
    10. Prepare 10 mL of 5% PGPE by diluting 500 µL of PGPE in 9.5 mL of ultrapure water. Use a 1 mL syringe to measure out PGPE as it is viscous. Cool it by placing it on ice.
    11. Cool the following centrifuge tubes by placing them on ice: 1.7 mL microcentrifuge tubes, 15 mL centrifuge tubes, 50 mL high-speed centrifuge tubes, and 13 mL ultracentrifuge tubes.
    12. Cool the required centrifuges to 4 °C: a microcentrifuge, a high-capacity centrifuge (for 15 mL tubes), a high-speed centrifuge (for 50 mL tubes), and an ultracentrifuge.
  2. Tissue preparation
    1. Use steps 1.2.1–1.2.9 to prepare the tissue for homogenization.
    2. Add 7 mL of cold tissue homogenate buffer and homogenize it on ice by moving the pestle up and down 20x. During the first five strokes, ensure the pestle goes to the bottom of the homogenizer.
    3. Transfer the homogenate to a cold 15 mL centrifuge tube.
    4. Rinse the homogenizer with 1 mL of cold tissue homogenate buffer and transfer it to the previously used 15 mL centrifuge tube.
    5. Bring the volume of the homogenate up to 10 mL with tissue homogenate buffer.
    6. Centrifuge the sample in a high-capacity centrifuge at 1,000 x g for 10 min at 4 °C.
    7. Transfer 8 mL of supernatant to a 50 mL centrifuge tube.
    8. Transfer 100 µL of the remaining supernatant as PNS sample for purity analysis.
  3. Sucrose gradient
    1. Tilt the 50 mL centrifuge tube containing the 8 mL of PNS at a 45° angle. Carefully add 6 mL of 40% sucrose solution, ensuring the two phases stay separate.
    2. In a similar fashion, slowly add 6 mL of 25% sucrose solution; then, add 4 mL of 10% sucrose solution; finally, add 8 mL of overlay buffer.
    3. Centrifuge the sample in a high-speed centrifuge at 30,000 x g at 4 °C for 30 min.
    4. Transfer the top layer containing the LDs to a 1.7 mL microcentrifuge tube.
    5. For LD washing, follow the steps in section 1.4.

Wyniki

We have performed the LD isolation with the ER kit on approximately 30 mice and compared the results with those following the sucrose isolation protocol on approximately 40 mice. The reported findings are typical for both protocols. Mice were fasted overnight with free access to water, to increase the LD yield. LD isolation using a sucrose gradient was run in parallel with the ER kit LD isolation protocol. Samples of PNS, PMS, PER, CLDs, and LDs were collected throughout the ER kit LD iso...

Dyskusje

Hepatic LD biology is increasingly being recognized as a critical regulator of hepatocellular physiology in both health and disease. As bona fide organelles, LDs are dynamic, interact with other cellular structures, and contain within them bioactive components involved in both lipid and glucose homeostasis. The sucrose gradient is routinely used for LD isolation and enables investigators to study LD structure, but it requires them to make numerous buffers. We have demonstrated that the use of a commercially available ER ...

Ujawnienia

Dr. Carr receives research support from Intercept Pharmaceuticals.

Podziękowania

We thank the Abramson Family Cancer Research Institute. This work is supported by following grants: NIH/NIAAA R01 AA026302-01, NIH/NIAAA K08-AA021424, Robert Wood Johnson Foundation, Harold Amos Medical Faculty Development Award, 7158, IDOM DRC Pilot Award P30 DK019525 (R.M.C.); NIH/NIAAA F32-AA024347 (J.C.). This work was supported in part by NIH P30-DK050306 and its core facilities (Molecular Pathology and Imaging Core, Molecular Biology/Gene Expression Core, and Cell Culture Core) and its pilot grant program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Materiały

NameCompanyCatalog NumberComments
BioExpress Vortex MixerGeneMateS-3200-1Vortex Mixer
Centrifuge 54242 REppendorf54242 RRefrigerated Counter Microcentrifuge
Rotor: FA-45-24-11
Centrifuge Sorvall RC6 +Thermo ScientificRC6+Refrigerated High Speed Centrifuge
Rotor: F21S-8x50y
Centrifuge Sorvall Legend RT+Thermo ScientificLegend RT+Refrigerated High Capacity Centrifuge
Rotor: 75006445 Bucket: 75006441
cOmplete Protease Inhibitor CocktailSigma Aldrich04 693 116 001Protease Inhibitor Tablets
Diagenode Bioruptur UCD-200DiagenodeUCD-200Sonication System
Dounce Tissue Grinder (45 mL)Wheaton357546Use Loose pestle
Dulbecco's Phosphate-Buffered Saline (1x)Corning21-031-CM
Endoplasmic Reticulum Isolation KitSigma AldrichER0100For ER kit Extraction:
Contains:
Isotonic Extraction Buffer 5X 100 mL
Hypotonic Extraction Buffer 10 mL
Calcium chloride, 2.5 M solution 5 mL
OptiPrep Density Gradient Medium 100 mL
Blunt Nosed Needle 1 ea.
External light source for flourescent excitationLeicaLeica EL6000
Hydrochloric acidSigma AldrichH1758Hydrochloric Acid
ImageJImage Analysis Software
Inverted Modulating Contrast MicroscopeLeicaLeica DM IRB
Lysosome Enrichment Kit for Tissues and Cultured CellsThermo Fisher Scientific89839For Lysosome Isolation
Microscope CameraQimagingQICAM fast 1394
Optima XL-100K UltracentrifugeBeckman-CoulterXL-100KUltracentrifuge
Rotor: SW41Ti
Pasteur PipettesFisher Scientific22-042817
Petri Dish 5 cmFisher ScientificFB0875713A
Pierce BCA Protein Assay KitThermo Fisher Scientific23225
PhosSTOPSigma Aldrich04 906 845 001Phosphatase Inhibior Tablets
Sterile Surgical Blade #10PioneerS2646
SucroseFisher ScientificS5-500Crystalline/Certified ACS
Triglyceride Liquicolor KitStanbio 2200-225Colorimetric Triglyceride kit
Tris BaseFisher ScientificBP152-1For TE buffer
Triton X-100Fisher BioReagentsBP151-1005%, Polyethylene glycol p-(1,1,3,3-tetramethylbutyl)-phenyl ether, Protein Lysis Reagent
UltraPure EDTA (0.5M, pH 8.0)Thermo Fisher Scientific15575-038For TE buffer

Odniesienia

  1. Brasaemle, D. L., Wolins, N. E. Isolation of Lipid Droplets from Cells by Density Gradient Centrifugation. Current Protocols in Cell Biology. 72, (2016).
  2. Ding, Y., et al. Isolating lipid droplets from multiple species. Nature Protocols. 8 (1), 43-51 (2013).
  3. Gao, Q., Goodman, J. M. The lipid droplet-a well-connected organelle. Frontiers in Cell and Developmental Biology. 3, 49 (2015).
  4. Correnti, J. M., et al. Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells. Scientific Reports. 8 (1), 12923 (2018).
  5. Williams, B., et al. A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. FASEB Journal. 32 (1), 130-142 (2018).
  6. Carr, R. M., Ahima, R. S. Pathophysiology of lipid droplet proteins in liver diseases. Experimental Cell Research. 340 (2), 187-192 (2016).
  7. Carr, R. M., et al. Perilipin Staining Distinguishes Between Steatosis and Nonalcoholic. Steatohepatitis in Adults and Children. Clinical Gastroenterology and Hepatology. 15 (1), 145-147 (2017).
  8. Carr, R. M., et al. Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology. 302 (8), R996-R1003 (2012).
  9. Carr, R. M., Peralta, G., Yin, X., Ahima, R. S. Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice. PLoS One. 9 (5), e97118 (2014).
  10. Tsai, T. H., et al. The constitutive lipid droplet protein PLIN2 regulates autophagy in liver. Autophagy. 13 (7), 1130-1144 (2017).
  11. Guo, Y., Cordes, K. R., Farese, R. V., Walther, T. C. Lipid droplets at a glance. Journal of Cell Science. 122 (Pt 6), 749-752 (2009).
  12. Liu, K., Czaja, M. J. Regulation of lipid stores and metabolism by lipophagy. Cell Death and Differentiation. 20 (1), 3-11 (2013).
  13. Mannik, J., Meyers, A., Dalhaimer, P. Isolation of cellular lipid droplets: two purification techniques starting from yeast cells and human placentas. Journal of Visualized Experiments. (86), e509814 (2014).
  14. Sato, S., et al. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. Journal of Biochemistry. 139 (5), 921-930 (2006).
  15. Wu, C. C., Howell, K. E., Neville, M. C., Yates, J. R., McManaman, J. L. Proteomics reveal a link between the endoplasmic reticulum and lipid secretory mechanisms in mammary epithelial cells. Electrophoresis. 21 (16), 3470-3482 (2000).
  16. Zhang, S., et al. Morphologically and Functionally Distinct Lipid Droplet Subpopulations. Scientific Reports. 6, 29539 (2016).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Lipid Droplet IsolationOrganelle Isolation KitLipid Droplet PurificationEndoplasmic ReticulumLysosomesLiver Tissue ProcessingCentrifugation ProtocolHomogenization TechniquePBS WashDounce HomogenizerBiological OrganellesCellular Lipid FluxProgressive Liver DiseaseMouse Dissection Method

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone